AstraZeneca | Results Presentation Deck | 44 slides · page 18 of 44
The slide uses a matrix-like structure to categorize trials by cancer type and development strategy (monotherapy vs. combinations vs. biomarker assessment).
Conference presentation · key_messages · summarize · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 disclaimer 1/1 list 1/1 table 1/1 title 2/2
Components 6
primary disclaimer bullet data action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1